SCHEMBL105486

Kakonein is a lipid of Polyketides (PK) class. Kakonein is associated with abnormalities such as Fatty Liver, Chronic liver disease, Morphologically altered structure, Hypertensive disease and Cardiovascular Diseases. The involved functions are known as protein expression, Extravasation, Liver damage, mRNA Expression and cell activation. Kakonein often locates in Body tissue, Hepatic, Microvilli, Cytoplasm and Membrane. The associated genes with Kakonein are TJP1 gene, CD14 gene, iberiotoxin, AT-Rich Interactive Domain-Containing Protein 1A and NKS1 gene. The related lipids are dehydrosoyasaponin I and Steroids. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of SCHEMBL105486, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with SCHEMBL105486?

SCHEMBL105486 is suspected in Chronic liver disease, Hypertensive disease, Cardiovascular Diseases, Myocardial Infarction, Cerebrovascular accident, Fatty Liver and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with SCHEMBL105486

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Alzheimer Disease D000544 76 associated lipids
Amnesia D000647 12 associated lipids
Angina Pectoris D000787 27 associated lipids
Angina, Unstable D000789 14 associated lipids
Arthritis D001168 41 associated lipids
Body Weight D001835 333 associated lipids
Burns D002056 34 associated lipids
Cataract D002386 34 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Coronary Disease D003327 70 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Diabetic Nephropathies D003928 39 associated lipids
Dyspepsia D004415 5 associated lipids
Endometriosis D004715 29 associated lipids
Fatty Liver D005234 48 associated lipids
Fever D005334 35 associated lipids
Heart Failure D006333 36 associated lipids
Hemolysis D006461 131 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Hypertension D006973 115 associated lipids
Hypertension, Renovascular D006978 10 associated lipids
Inflammation D007249 119 associated lipids
Insulin Resistance D007333 99 associated lipids
Lead Poisoning D007855 4 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Memory Disorders D008569 33 associated lipids
Parkinson Disease D010300 53 associated lipids
Urinary Incontinence D014549 4 associated lipids
Reperfusion Injury D015427 65 associated lipids
Glucose Intolerance D018149 13 associated lipids
Alcohol-Related Disorders D019973 3 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neurotoxicity Syndromes D020258 34 associated lipids
Brain Infarction D020520 17 associated lipids
Stroke D020521 32 associated lipids
Chemical and Drug Induced Liver Injury D056486 39 associated lipids
Per page 10 20 50 | Total 43

PubChem Associated disorders and diseases

What pathways are associated with SCHEMBL105486

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with SCHEMBL105486?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with SCHEMBL105486?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with SCHEMBL105486?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with SCHEMBL105486?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with SCHEMBL105486?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with SCHEMBL105486

Download all related citations
Per page 10 20 50 100 | Total 919
Authors Title Published Journal PubMed Link
Park SJ et al. Effects of mixed herbal extracts from parched Puerariae radix, gingered Magnoliae cortex, Glycyrrhizae radix and Euphorbiae radix (KIOM-79) on cardiac ion channels and action potentials. 2009 J. Korean Med. Sci. pmid:19543501
Zhang CP et al. Genistein-3'-sulfonic acid dihydrate. 2009 Acta Crystallogr Sect E Struct Rep Online pmid:21583946
Zhang BQ and Wang YL [Effects of puerarin on hippocampal synaptic long term potentiation in vascular dementia rats]. 2009 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21155222
Teng Y et al. Protective effect of puerarin on diabetic retinopathy in rats. 2009 Mol. Biol. Rep. pmid:18587665
Zhang H and Yang X Profiling and quantification of isoflavone-C-glycosides impurities in puerarin injection by liquid chromatography coupled to ESI-ion trap mass spectrometry. 2009 J Pharm Biomed Anal pmid:19186018
Yan LP et al. Analysis of the mechanisms underlying the endothelium-dependent antivasoconstriction of puerarin in rat aorta. 2009 Naunyn Schmiedebergs Arch. Pharmacol. pmid:19190894
Zheng P et al. Therapeutic effect of puerarin on non-alcoholic rat fatty liver by improving leptin signal transduction through JAK2/STAT3 pathways. 2009 Am. J. Chin. Med. pmid:19222113
Zhu CQ et al. [Preparation technology of Zhangyanming dispersible tablet and determination of puerarin by HPLC]. 2009 Zhong Yao Cai pmid:19771855
Han J et al. [Protective effect of 3'-methoxy puerarin on cerebral ischemic injury/ reperfusion in rats]. 2009 Zhongguo Zhong Yao Za Zhi pmid:19771877
Xu C et al. Effect of puerarin on P2X3 receptor involved in hyperalgesia after burn injury in the rat. 2009 Brain Res. Bull. pmid:19744545
Cheng YF et al. Involvement of ubiquitin proteasome system in protective mechanisms of Puerarin to MPP(+)-elicited apoptosis. 2009 Neurosci. Res. pmid:19022306
Prasain JK et al. Tissue distribution of puerarin and its conjugated metabolites in rats assessed by liquid chromatography-tandem mass spectrometry. 2009 Phytomedicine pmid:19027277
Wu H et al. Enhanced oral bioavailability of puerarin using microemulsion vehicle. 2009 Drug Dev Ind Pharm pmid:19040180
Lin YJ et al. Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells. 2009 Biochem. Biophys. Res. Commun. pmid:19013426
Yu CQ et al. [Regulatory mechanism of malignant behavior of endometriosis mediated by puerarin]. 2009 Zhong Xi Yi Jie He Xue Bao pmid:19134456
Shen JG et al. Effects of puerarin on receptor for advanced glycation end products in nephridial tissue of streptozotocin-induced diabetic rats. 2009 Mol. Biol. Rep. pmid:19125353
Qin F et al. Pharmacokinetic comparison of puerarin after oral administration of Jiawei-Xiaoyao-San to healthy volunteers and patients with functional dyspepsia: influence of disease state. 2009 J. Pharm. Pharmacol. pmid:19126307
Chen AZ et al. Microencapsulation of puerarin nanoparticles by poly(l-lactide) in a supercritical CO(2) process. 2009 Acta Biomater pmid:19463980
Gao L et al. Puerarin protects against ischemic brain injury in a rat model of transient focal ischemia. 2009 Neurol. Res. pmid:19508827
Li X et al. Evaluation of Pharmasolve corneal permeability enhancement and its irritation on rabbit eyes. 2009 Drug Deliv pmid:19514982
Jin G et al. [Effects of puerarin on expression of apelin and its receptor of 2K1C renal hypertension rats]. 2009 Zhongguo Zhong Yao Za Zhi pmid:20353015
Yang L et al. [Screening and identification of a fungal strain functioning in hydroxylation of puerarin]. 2009 Wei Sheng Wu Xue Bao pmid:20222440
Jiang XX et al. [Effect of puerarin preconditioning on cytokine levels in patients undergoing cardiopulmonary bypass in perioperative period]. 2009 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:20214329
Han MX et al. [Identification of three-step IR spectra of radix Puerariae from different habitats]. 2009 Guang Pu Xue Yu Guang Pu Fen Xi pmid:19798956
Yang S et al. [Effect of puerarin on liver injury in KKAy mice with type 2 diabetes mellitus]. 2009 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:19848202
Gao L et al. [Of berberine and puerarin on dexamethasone-induced insulin resistance in porcine ovarian thecal cells]. 2009 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:19852296
Han J et al. [Inhibitory effects of puerarin on invasion and metastasis of oophoroma cells HO-8910]. 2009 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:19852298
Liu XJ et al. [Study on absorption mechanism of puerarin and its nanoparticles across Caco-2 cell model]. 2009 Zhong Yao Cai pmid:19960950
Wang L et al. [The pathway of absorption and conveying of puerarin microemulsion-in-oil]. 2009 Yao Xue Xue Bao pmid:19806923
Zhang X et al. [Pharmacokinetics of puerarin and hydrochlorothiazide from maijunan tablets in rats]. 2009 Yao Xue Xue Bao pmid:20055185
Xiao J et al. Glycosylation of dietary flavonoids decreases the affinities for plasma protein. 2009 J. Agric. Food Chem. pmid:19722570
Retraction. The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin. 2009 Phytother Res pmid:19391125
Retraction. Cardioprotective effects of the combined use of puerarin and danshensu on acute ischemic myocardial injury in rats. 2009 Phytother Res pmid:19391124
Lu N et al. Nitrite-glucose-glucose oxidase system directly induces rat heart homogenate oxidation and tyrosine nitration: effects of some flavonoids. 2009 Toxicol In Vitro pmid:19286453
Derda M et al. Plant extracts as natural amoebicidal agents. 2009 Parasitol. Res. pmid:19050923
Tian J and Qin W Quick and sensitive determination of flavonoids by capillary electrophoresis-potential gradient detection. 2009 Anal Sci pmid:19745540
Li Q et al. Effect of puerarin on the expression of extracellular matrix in rats with streptozotocin-induced diabetic nephropathy. 2009 Jan-Feb Natl Med J India pmid:19761151
Meng XH et al. Puerarin protects against high glucose-induced acute vascular dysfunction: role of heme oxygenase-1 in rat thoracic aorta. 2009 Mar-Apr Vascul. Pharmacol. pmid:19073281
Feng ZQ et al. The synthesis of puerarin derivatives and their protective effect on the myocardial ischemia and reperfusion injury. 2010 J Asian Nat Prod Res pmid:20924897
Yang X et al. Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris. 2010 Basic Clin. Pharmacol. Toxicol. pmid:20346059
Liu Y et al. [Corneal penetration of PAMAM dendrimers-coated puerarin liposomes]. 2010 Zhongguo Zhong Yao Za Zhi pmid:20349711
Semalty A et al. Development and evaluation of pharmacosomes of aceclofenac. 2010 Indian J Pharm Sci pmid:21694988
Kato E and Kawabata J Glucose uptake enhancing activity of puerarin and the role of C-glucoside suggested from activity of related compounds. 2010 Bioorg. Med. Chem. Lett. pmid:20605096
Liu X et al. A validated stability-indicating HPLC method for the determination of PEGylated puerarin in aqueous solutions. 2010 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:20580327
Zhang R et al. [Protective effect of puerarin against calcium overload after focal cerebral ischemia injury in rats]. 2010 Nan Fang Yi Ke Da Xue Xue Bao pmid:20584654
Yao W et al. Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system. 2010 Drug Dev Ind Pharm pmid:20545508
Xu J et al. PVA hydrogels containing beta-cyclodextrin for enhanced loading and sustained release of ocular therapeutics. 2010 J Biomater Sci Polym Ed pmid:20507706
Zhu G et al. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease. 2010 Planta Med. pmid:20509103
Malaivijitnond S et al. Puerarin exhibits weak estrogenic activity in female rats. 2010 Fitoterapia pmid:20117180
Fan X et al. Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury. 2010 Curr Neuropharmacol pmid:21629441